1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.
2. Ministry for Health, Welfare and Family Affairs. Annual report of cancer incidence(2007), cancer prevalence (2007) and survival (1993–2007) in Korea. Seoul: Ministry for Health, Welfare and Family Affairs. 2009:
3. Giaccone G. Clinical perspectives on platinum resistance. Drugs. 2000;59(4):9–17.
4. Park HJ, Lee SH, Son DJ, et al. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum. 2004;50(11):3504–15.
5. Park JH, Jeong YJ, Park KK, et al. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Mol Cells. 2010;29(2):209–15.
6. Park MH, Choi MS, Kwak DH, et al. Anti cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-
β. Prostate. 2010;61(1):801–12.
7. Liu S, Yu M, He Y, et al. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology. 2008;47(6):1964–73.
8. Takeo S, Yasumoto K, Nagashima A, Nakahashi H, Sugimachi K, Nomoto K. Role of tumor-associated macrophages in lung cancer. Cancer Res. 1986;46(6):3179–82.
9. Takanami I, Takeuchi K, Giga M. The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thorac Cardiovasc Surg. 2001;121(6):1058–63.
10. Villegas FR, Coca S, Villarrubia VG, et al. Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer. 2002;35(1):23–8.
11. Jang DM, Song HS. Inhibitory Effects of Bee Venom on Growth of A549 Lung Cancer Cells via Induction of Death Receptors. The Acupuncture. 2012;30(1):57–70.
12. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer. 2002;2(11):850–61.
14. Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in Immuno-therapy of human cancer. Nature Reviews Immunology. 2007;7(5):329–39.
15. Chan CJ, Andrews DM, Smyth MJ. Can NK cells be a therapeutic target in human cancer. Eur J Immunol. 2008;38(11):2964–8.
16. Cerwenka A, Falk CS, Watzl C. NK cells-from basic research to cancer therapy. Eur J Immunol. 2007;37(5):1161–4.
17. Mori M, Ohtani H, Naito Y, et al. Infiltration of CD81 T cells in non-small cell lung cancer is associated with dedifferentiation of cancer cells, but not with prognosis. Tohoku J Exp Med. 2000;191(5):113–8.
18. Wakabayashi O, Yamazaki K, Oizumi S, et al. CD41 T cells in cancer stroma, not CD81 T cells in cancer cell nests, are associated with favorable prognosis in human nonsmall cell lung cancers. Cancer Sci. 2003;94(11):1003–9.
19. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47(7):176, , 187.
20. Lanier LL. Nk Cell Recognition. Annual Review of Immunology. 2005;23(1):225–74.
22. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nature Immunology. 2008;9(5):503–10.
24. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nature Rev Immunol. 2001;1(1):41–9.
25. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22(11):633–40.
26. Screpanti V, Wallin RP, Grandien A, Ljunggren HG. Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells. Mol Immunol. 2005;42(4):495–9.
29. Mukai Y, Shibata H, Nakamura T, et al. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant. J Mol Biol. 2009;385(4):1221–9.
30. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-
κB activation. Cell. 1995;81(4):495–504.
31. Wilson NS, Dixit V, Ashkenazi A. Death receptor signal transducers : nodes of coordination in immune signaling networks. Nature Immunol. 2009;10(3):348–55.
32. Wang S, El-Deiry WS. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene. 2003;22(53):8628–33.
33. Osawa K, Takami N, Shiozawa K, Hashiramoto A, Shiozawa S. Death receptor 3(DR3) gene duplication in a chromosome region 1p36.3: gene duplication is more prevalent in rheumatoid arthritis. Genes Immun. 2004;5(6):439–43.
34. Henkart PA. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity. 1994;1(5):343–6.
35. Kojima H, Shinohara N, Hanaoka S, et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity. 1994;1(5):357–64.
36. Cifone MG, Ulisse S, Santoni A. Natural killer cells and Nitric Oxide. Int Immunopharmacol. 2001;1(8):1513–24.